advertisement
 |
|
|
In this preshow newsletter, stay up to date on conference keynote addresses, exhibitor updates, and more from CPhI North America 2019. See www.cphinorthamerica.com for more details.
|
|
Pharma industry exhibition and conference to convene in Chicago on April 30–May 2, 2019.
/ read more /
CPhI NORTH AMERICA CONFERENCE LINEUP
Tuesday, April 30, 9:45am–10:30am
Formulation experts will discuss roadblocks to patient adherence as well as technologies and processes that can be employed to mitigate these problems.
/ read more /
Tuesday, April 30, 10:30am–11:15am
Trends, regulatory considerations, case studies, and the future of supporting high potent drug product manufacturing will be discussed from the perspective of a contract development and manufacturing organization (CDMO).
/ Read more /
|
|
|
Tuesday, April 30, 11:45am–12:30pm
This panel discussion will explore environmental safety and health challenges, strategies on compliance, and how to gain a voice on Capitol Hill.
/ Read more /
Tuesday, April 30, 1:30pm–2:15pm
Senator Flake shares opinions on pharma manufacturing, healthcare innovation, and the direction of healthcare in our current structure of government, as well as scenarios beyond 2020.
/ Read more /
|
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers |
 |
|
|
NEWS FROM CPhI NORTH AMERICA EXHIBITORS
A $1.7-billion acquisition of CDMO Brammer Bio establishes Thermo Fisher Scientific in viral vector manufacturing.
/ Read more /
Catalent announces investment for its Zydis ODT technology, offering increased drug load and taste-masking capabilities.
/ Read more /
Alcami Biologics formed to meet market demands for biological drug development services.
/ Read more /
A $100-million investment will expand a range of the CDMO's service capabilities and offerings.
/ Read more /
The company will add a cGMP packaging line and a new filler on its existing packaging line at its Mirabel, Québec, Canada, site.
/ Read more /
|
|
|
|
CPhI NORTH AMERICA 2019 EXHIBITOR PREVIEW
 |
AbbVie Contract Manufacturing has been serving our partners for more than 40 years across 10 of our manufacturing facilities located in both North America and Europe.
/ Learn more / |
 |
For over 40 years, Albemarle's Fine Chemistry Services (FCS) group has successfully delivered new products into the marketplace that require active pharmaceutical ingredients (APIs) and custom drug intermediaries.
/ Learn more / |
 |
At Ashland, our goal is to help you apply pharmaceutical polymers to develop your formulations.
/ Learn more / |
 |
Cambrex's recent acquisitions of Halo Pharma and Avista Pharma Solutions have expanded its business to offer end-to-end services for small-molecule therapeutics, which will be showcased at CPhI North America.
/ Learn more / |
 |
Catalent Pharma Solutions offers its partners end-to-end solutions, from drug formulation and drug delivery technologies, to manufacturing and clinical supply services.
/ Learn more / |
|
|
|
|
|
